Enzon Pharmaceuticals, Inc. Common Stock

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch ENZN and buy or sell other stocks, ETFs, and their options commission-free!

About ENZN

Manufactures and sells pharmaceuticals ENZN is listed on the OTCQX U.S. market tier. OTC market data is provided by OTC Markets Group, Inc (otcmarkets.com). 

CEO
Thomas Dale Davis, MBA
CEOThomas Dale Davis, MBA
Employees
Employees
Headquarters
Lombard, Illinois
HeadquartersLombard, Illinois
Founded
Founded
Employees
Employees

ENZN Key Statistics

Market cap
97.84M
Market cap97.84M
Price-Earnings ratio
-0.93
Price-Earnings ratio-0.93
Dividend yield
Dividend yield
Average volume
350.78
Average volume350.78
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$8.55
52 Week high$8.55
52 Week low
$1.50
52 Week low$1.50

Stock Snapshot

With a market cap of 97.84M, Enzon Pharmaceuticals, Inc. Common Stock(ENZN) trades at $6.83. The stock has a price-to-earnings ratio of -0.93.

On 2026-09-08, Enzon Pharmaceuticals, Inc. Common Stock(ENZN) shares started trading at —, with intraday highs of — and lows of —.

Trading volume for Enzon Pharmaceuticals, Inc. Common Stock(ENZN) stock has reached 0, versus its average volume of 350.78.

The stock's 52-week range extends from a low of $1.50 to a high of $8.55.

The stock's 52-week range extends from a low of $1.50 to a high of $8.55.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.